Recruiting Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer NCT06253494 Conditions Cancer of Endometrium, Carcinoma of Endometrium, Endometrial Cancer, +13 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma NCT02387645 Conditions Cancer of Endometrium, Carcinoma of Endometrium, Endometrial Neoplasms, +11 more Locations Medical University Vienna, Dptm. of Obstetrics & Gynaecology — Vienna, Austria View Trial Details
